The Effects of Moviprep With Simethicone on Colonic Bubbles

• Status: Completed
• Trial end date: 2012-09-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine whether the administration of PEG along with simethicone will reduce the incidence of colonic bubbles that interfere with polyp detection.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Thomas Jefferson University
• Treatments: Aluminum Hydroxide; Aluminum hydroxide, magnesium hydroxide, drug combination; Aluminum hydroxide, magnesium hydroxide, simethicone drug combination; Magnesium Hydroxide; Simethicone; TEMPO

Criteria

Inclusion Criteria:

-Elective outpatients undergoing colonoscopy using split dose PEG-ELS with sodium ascorbate and ascorbic acid

Exclusion Criteria:

• Unable or unwilling to give informed consent

• Age < 18 years

• Pregnant

• Breast feeding

• Established or suspected gastroparesis

• Pseudo-obstruction - established or suspected

• Severe constipation (< 1 BM a week)

• Bowel obstruction

• Greater than 50% resection of colon

• Chronic nausea or vomiting

• Consumed > 100% standard dose of PEG-ELS (i.e. more than 2L)

• G6PD deficiency

• PEG allergy

• Significant psychiatric illness